Basit öğe kaydını göster

dc.contributor.authorBaykal, Hüsnü
dc.contributor.authorÜlger, A. Füsun
dc.contributor.authorÇelik, Deniz
dc.contributor.authorTanrıkulu, Fatma Benli
dc.contributor.authorTatçı, Ebru
dc.date.accessioned2023-10-09T08:16:52Z
dc.date.available2023-10-09T08:16:52Z
dc.date.issued2022en_US
dc.identifier.urihttps://www.scopus.com/record/display.uri?eid=2-s2.0-85128797236&origin=resultslist&sort=plf-f&src=s&nlo=&nlr=&nls=&sid=20c4fe371b9b908d4f7e419f791331ff&sot=aff&sdt=cl&cluster=scofreetoread%2c%22all%22%2ct&sl=72&s=AF-ID%28%22Alanya+Alaaddin+Keykubat+University%22+60198720%29+AND+SUBJAREA%28MEDI%29&relpos=81&citeCnt=0&searchTerm=
dc.identifier.urihttps://hdl.handle.net/20.500.12868/2405
dc.description.abstractINTRODUCTION: Pulmonary actinomycosis, clinically and radiologically, mimics abscess, tuberculosis, and lung malignancy, resulting in misdiagnosis or delay in diagnosis. In this study, we analyzed the clinicoradiological features of pulmonary actinomycosis, the presence of any differences between clinical prediagnosis and radiological diagnosis, and whether imaging modalities help distinguish pulmonary actinomycosis from lung cancer. METHODS: A total of 22 patients who had a histopathological diagnosis of actinomycosis in a tertiary health center participated in this study. Of these, 14 had positron-emission tomography/computed tomography. RESULTS: In all, 81.8% of the patients were males. The diagnostic procedures employed for the diagnosis of actinomycosis were surgery in 54.5% of patients, fiberoptic bronchoscopy in 36.4% of patients, and rigid bronchoscopy in 9.1% of patients. Radiological and clinical prediagnosis showed malignancy in 31.8 and 40.9% of patients, respectively. The mean of the maximum standardized uptake value was 6.33±3.6 on positron-emission tomography/computed tomography. Kappa compliance analysis revealed that clinical and radiological diagnoses were significantly compatible with each other and that radiological pre-diagnoses were not superior to clinical diagnoses (κ=0.701 and p<0.001). CONCLUSION: Pulmonary actinomycosis shows high metabolic uptake in positron-emission tomography/computed tomography, and this may mislead clinicians for a diagnosis of malignancy. Our results suggest that positron-emission tomography/computed tomography does not help distinguish pulmonary actinomycosis from lung malignancy and does not provide a clear diagnostic benefit to the clinician, so pathological diagnosis is necessary.en_US
dc.language.isoengen_US
dc.relation.isversionof10.1590/1806-9282.20211017en_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subjectActinomycosisen_US
dc.subjectNeoplasmsen_US
dc.subjectTomographyen_US
dc.subjectPositron-emission tomographyen_US
dc.titleClinical and radiological characteristics of pulmonary actinomycosis mimicking lung malignancyen_US
dc.typearticleen_US
dc.contributor.departmentALKÜ, Fakülteler, Tıp Fakültesi, Dahili Tıp Bilimleri Bölümüen_US
dc.identifier.volume68en_US
dc.identifier.issue3en_US
dc.identifier.startpage372en_US
dc.identifier.endpage376en_US
dc.relation.journalRevista da Associacao Medica Brasileiraen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US


Bu öğenin dosyaları:

Thumbnail

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster